Back
Stoke Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
STOK
Stoke Therapeutics, Inc.
Last Price:
$31.15
Seasonality Move:
11.61%
7 Day Trial
ALL ACCESS PASS
$
7
Stoke Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 42.7% based on the past 6 years of stock performance.
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Stoke Therapeutics, Inc. Stock Undervalued?The current Stoke Therapeutics, Inc. [STOK] share price is $31.91. The Score for STOK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
STOK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Stoke Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 42.7% based on the past 6 years of stock performance.
Stoke Therapeutics, Inc. Stock Rating
Sell
46
Stoke Therapeutics, Inc. (STOK)
is a Sell
Is Stoke Therapeutics, Inc. overpriced?
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Stoke Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com
52-Week Data
52-Week High:
38.69
52-Week Low:
5.35
Prediction Charts
Market Cap:
1.8B
Price in USD:
31.91
Volume:
510K
Beta:
0.95
Technical Analysis
SMA50:
31.62
SMA100:
30.01
SMA200:
21.96
52-Wk Change:
200.19%
Stock Predictions
-
Is Stoke Therapeutics, Inc. stock public?Yes, Stoke Therapeutics, Inc. is a publicly traded company.
-
What is the Stoke Therapeutics, Inc. stock quote today?The Stoke Therapeutics, Inc. stock price is 31.91 USD today.
-
How to buy Stoke Therapeutics, Inc. stock online?You can buy Stoke Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 29.25 | 29.51 | 30.25 | 29.07 |
| Jan-28 | 29.67 | 29.40 | 30.14 | 29.14 |
| Jan-29 | 29.40 | 31.07 | 31.76 | 29.29 |
| Jan-30 | 30.56 | 30.34 | 31.08 | 29.96 |
| Feb-2 | 30.00 | 30.77 | 31.49 | 29.35 |
| Feb-3 | 31.02 | 33.79 | 33.83 | 31.01 |
| Feb-4 | 34.11 | 32.00 | 34.47 | 30.67 |
| Feb-5 | 32.43 | 30.48 | 34.01 | 30.33 |
| Feb-6 | 31.70 | 32.40 | 33.48 | 31.06 |
| Feb-9 | 31.77 | 31.99 | 32.38 | 30.75 |
| Feb-10 | 30.90 | 32.44 | 32.95 | 30.79 |
| Feb-11 | 32.49 | 32.22 | 32.90 | 30.91 |
| Feb-12 | 32.95 | 31.89 | 33.28 | 31.47 |
| Feb-13 | 32.35 | 31.91 | 33.24 | 31.58 |
Stoke Therapeutics, Inc. Earnings
Stoke Therapeutics, Inc. Earnings Report: Per Share Stoke Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Stoke Therapeutics, Inc. Forecast Revenue Growth
Stoke Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.18 per share, and an increase next year of $0.61 per share.
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.